Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary
Kim Papp(University of Toronto), John Wade(St Thomas' Hospital), John K. Marshall(McMaster University), Janet Pope(St Joseph's Health Care), Alain Bitton(McGill University Health Centre), Robert Bissonnette(Innovaderm (Canada)), Boulos Haraoui(Centre Hospitalier de l’Université de Montréal), Shahin Jamal(Vancouver Coastal Health), Deepali Kumar(University Health Network), Brian Bressler(University of British Columbia), Vincent Ho(University of British Columbia), A. Hillary Steinhart(Mount Sinai Hospital), Donald C. Vinh(McGill University Health Centre), Melinda Gooderham(Queen's University)
Cited by 27
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k